MESOTHELIOMA | 2026-10-27

Proving Exposure to a Specific Defendant’s Asbestos Product: The Threshold-Causation Standard of McGonnell, Lineaweaver, and Rutherford in California Mesothelioma Cases

A mesothelioma plaintiff cannot recover from an asbestos defendant simply by showing the defendant’s product was somewhere nearby. California requires proof of threshold exposure to that specific defendant’s product, plus proof that the exposure was a substantial factor in causing the disease. McGonnell v. Kaiser Gypsum, Lineaweaver, and Rutherford set that standard. This guide explains what the evidence must show.

Mesothelioma is caused almost exclusively by exposure to asbestos , often decades before the disease appears. By the time a California worker is diagnosed, the products are long gone, the job sites have changed, and memories have faded. A central challenge in every asbestos case is therefore proof o

In an asbestos case, liability does not attach to a company simply because it once made an asbestos product. The plaintiff must connect this defendant’s product to this plaintiff’s exposure, and then connect that exposure to the disease. Because mesothelioma has a latency period of decades and because asbestos was used in thousands of products across countless job sites, product identification and exposure proof are frequently the decisive issues. This article explains the two-part causation standard California applies, how courts have drawn the line between sufficient and insufficient evidence, and how a strong exposure case is built.

The Two-Part Causation Requirement

California courts describe the plaintiff’s burden in asbestos cases as a two-part showing. As the Court of Appeal put it in McGonnell v. Kaiser Gypsum Co. (2002) 98 Cal.App.4th 1098, a plaintiff must prove (1) some threshold exposure to the defendant’s asbestos-containing product, and (2) that the exposure was, in reasonable medical probability, a substantial factor in contributing to the plaintiff’s risk of developing the disease. Both parts must be satisfied. The first is a factual, product-identification question: was the plaintiff actually exposed to this defendant’s product at all? The second is a medical-causation question, generally proved through expert testimony: did that exposure make a meaningful contribution to the plaintiff’s aggregate dose and risk?

McGonnell: No Exposure Means No Causation

McGonnell illustrates the first part. The plaintiff worked at a bank and was exposed to joint compound and other products during remodeling, but the evidence that he encountered the specific defendant’s asbestos products was thin — it rested on the possible presence of such products rather than proof the plaintiff actually worked with or around them. The Court of Appeal affirmed summary judgment for the defendant, explaining that the plaintiff’s evidence established, at most, that the defendant’s products might have been present, which is not the same as proof of exposure. The court’s core principle is often quoted: "If there has been no exposure, there is no causation." Speculation that a product was somewhere in a building does not substitute for evidence that the plaintiff was actually exposed to it.

Lineaweaver: The Substantial-Factor Framework

The second part traces to Lineaweaver v. Owens-Corning Fiberglas Corp. (1995) 31 Cal.App.4th 1409. There, the Court of Appeal adopted the substantial-factor test for asbestos causation and explained how to apply it. The court recognized that the substantial-factor standard was "formulated to aid plaintiffs as a broader rule of causality than the ‘but for’ test," because no one can say which specific fiber from which specific product triggered a particular plaintiff’s cancer. But the court also warned that the test cannot be stretched to reach defendants whose contribution was insubstantial or merely theoretical. Lineaweaver identified the factors relevant to exposure — the frequency of exposure, the regularity of exposure, and the proximity of the asbestos product to the plaintiff — as the kind of evidence that can establish a substantial factor, while cautioning that these factors are relevant but not always dispositive.

Rutherford: Contribution to Risk, Not to the Specific Fiber

The California Supreme Court completed the framework in Rutherford v. Owens-Illinois, Inc. (1997) 16 Cal.4th 953. Rutherford held that a plaintiff need not prove that fibers from a particular defendant’s product were the ones that actually caused the malignant cell — an impossible burden given the science. Instead, the plaintiff proves causation by showing, in reasonable medical probability, that exposure to the defendant’s product was a substantial factor contributing to the aggregate dose of asbestos the plaintiff inhaled or ingested, and hence to the risk of developing asbestos-related cancer. Rutherford thus frames the medical-causation question in terms of contribution to risk, decided through expert testimony, rather than tracing a specific fiber to a specific tumor. This is what makes the substantial-factor test workable in the mesothelioma context.

The Line Between "Probable" and "Possible"

Lineaweaver drew a careful line that still governs. A possible cause becomes a probable cause only when, in the absence of other reasonable causal explanations, it becomes more likely than not that the injury resulted from its action. Evidence that merely establishes a possibility of exposure — that a product could have been present, or that the plaintiff might have encountered it — does not meet the plaintiff’s burden. The exposure evidence must support a reasonable inference of actual, repeated exposure, not a theoretical chance of it. This is the principle that defeated the claim in McGonnell and that defendants invoke on summary judgment in nearly every asbestos case.

"Substantial" Without an Undue Burden: Jones v. John Crane

Courts have been careful not to turn "substantial factor" into an impossible hurdle. In Jones v. John Crane, Inc. (2005) 132 Cal.App.4th 990, the Court of Appeal explained that the plaintiff’s evidence must show the product contributed to the disease in a way that is more than negligible or theoretical, but that courts should not place an "undue burden" on the word "substantial." The point is that a genuine, repeated exposure that a qualified expert links to the plaintiff’s aggregate dose can be a substantial factor even though it is impossible to quantify its precise contribution. The standard filters out trivial or speculative exposures while allowing real ones to reach the jury.

Expert Medical Testimony Is Required

Under Rutherford, causation in an asbestos case generally must be established through expert medical testimony. A treating physician or qualified expert explains that mesothelioma is a dose-responsive disease, that each significant exposure contributes to the cumulative dose and thus to the risk, and that the plaintiff’s exposure to the defendant’s product was a substantial contributing factor. California courts also require that expert opinion rest on a reasoned factual basis rather than speculation — the principle associated with Sargon Enterprises, Inc. v. University of Southern California (2012) 55 Cal.4th 747 — so the expert’s conclusions must be tied to the actual exposure evidence developed in the case. The interplay of solid exposure facts and sound expert testimony is what carries the plaintiff’s burden.

Building the Product-Identification Case

Because exposure proof is decisive, the investigation in an asbestos case is intensive and begins immediately. Counsel develops the plaintiff’s complete work and life history: every job, job site, trade, and task, and the products encountered at each. Evidence of product identification comes from the plaintiff’s own testimony where the plaintiff is able to give it, from co-worker testimony, from purchase and specification records, from contractor and supplier documents, and from the extensive historical record about which manufacturers’ products were used in particular industries and eras. In mesothelioma cases especially, where a single significant exposure can be legally sufficient, the goal is to establish actual, repeated contact with each defendant’s product — not merely its presence in the general vicinity.

Secondary and Take-Home Exposure

Exposure is not limited to the worker who handled the product. California recognizes take-home or secondary exposure claims, where a household member was exposed to asbestos fibers carried home on a worker’s clothing, skin, or hair. The duty owed to household members was addressed by the Supreme Court in Kesner v. Superior Court (2016) 1 Cal.5th 1132, which recognized that employers and premises owners may owe a duty of care to members of a worker’s household against take-home exposure. The causation standard for a take-home plaintiff is the same two-part McGonnell/Rutherford framework — threshold exposure to the defendant’s product plus substantial-factor contribution — but the exposure pathway runs through the worker’s contaminated clothing rather than direct handling.

How Defendants Attack Exposure Evidence

Asbestos defendants routinely move for summary judgment on the ground that the plaintiff cannot prove exposure to their product. They argue, as in McGonnell, that the evidence shows at most that their product might have been present, which is legally insufficient. They scrutinize the plaintiff’s and witnesses’ ability to identify the specific brand, the frequency and duration of any contact, and whether the product actually contained asbestos during the relevant period. A plaintiff defeats these motions with concrete, admissible evidence of actual, repeated exposure tied to the defendant’s product, supported by expert testimony linking that exposure to the aggregate dose and risk. Anticipating the summary-judgment attack shapes how the exposure case is developed from day one.

Why This Standard Matters to Your Case

The two-part causation standard is the battleground of almost every California asbestos case. A claim can be legally sound on duty and damages yet fail if the plaintiff cannot prove actual exposure to a specific defendant’s product and a qualified expert cannot tie that exposure to the disease. Conversely, a well-developed exposure record — built from work history, co-worker testimony, product records, and sound expert analysis — can establish a substantial factor even decades after the exposure. For diagnosed workers and their families, acting quickly to preserve testimony and documents is critical, because the witnesses who can identify the products are themselves aging and the records grow harder to find with time.

Frequently Asked Questions

Is it enough to show a defendant’s asbestos product was at my job site?

No. Under McGonnell v. Kaiser Gypsum (2002) 98 Cal.App.4th 1098, mere presence of a product is not enough. You must prove actual threshold exposure to that specific defendant’s asbestos-containing product. As the court put it, "If there has been no exposure, there is no causation."

What is the "substantial factor" test?

It is the causation standard from Lineaweaver and Rutherford. The plaintiff proves that exposure to the defendant’s product was, in reasonable medical probability, a substantial factor contributing to the aggregate dose of asbestos and thus to the risk of developing the disease. It is broader than but-for causation but excludes trivial or theoretical contributions.

Do I have to prove which fiber caused my cancer?

No. Rutherford v. Owens-Illinois (1997) 16 Cal.4th 953 holds that a plaintiff need not identify the specific fibers that caused the malignant cell. Instead, the plaintiff shows that exposure to the defendant’s product was a substantial factor contributing to the total dose and the overall risk of disease.

What is the difference between a "possible" and a "probable" cause?

Lineaweaver explains that a possible cause becomes probable only when, absent other reasonable explanations, it is more likely than not that it caused the injury. Evidence showing only that exposure was possible does not meet the plaintiff’s burden; the evidence must support actual, repeated exposure.

How much exposure is enough?

There is no fixed quantity. The exposure must be more than negligible or theoretical (Jones v. John Crane (2005) 132 Cal.App.4th 990), but courts do not place an undue burden on the word "substantial." A genuine, repeated exposure that an expert links to the aggregate dose can qualify, even if its precise contribution cannot be measured.

Do I need expert testimony?

Generally yes. Under Rutherford, causation in asbestos cases is established through expert medical testimony explaining that mesothelioma is dose-responsive and that the plaintiff’s exposure to the defendant’s product was a substantial contributing factor. The expert’s opinion must rest on the actual exposure evidence, not speculation.

Can a family member exposed at home bring a claim?

Yes. California recognizes take-home exposure claims. Kesner v. Superior Court (2016) 1 Cal.5th 1132 held that employers and premises owners may owe a duty to household members exposed to asbestos carried home on a worker’s clothing. The same two-part causation standard applies.

How do defendants try to defeat exposure claims?

They move for summary judgment arguing the plaintiff cannot prove exposure to their specific product, contending the evidence shows at most that the product might have been present. A plaintiff defeats these motions with concrete evidence of actual, repeated exposure tied to the defendant’s product and supported by expert testimony.

Each Defendant Is Evaluated Separately

A mesothelioma plaintiff is typically exposed to products from many manufacturers over a working life, and the causation standard applies to each defendant individually. The plaintiff must establish threshold exposure to that defendant's product and a substantial-factor contribution from that defendant's product; a strong case against one manufacturer does not carry a weak case against another. This is why product identification is developed defendant-by-defendant, and why some defendants are dismissed on summary judgment while others remain. Under California's several-liability rule for noneconomic damages (Civil Code §1431.2, the Proposition 51 regime), each defendant found liable is responsible for noneconomic damages only in proportion to its own share of fault, which makes the individualized exposure proof against each defendant consequential not just to liability but to the ultimate allocation of damages. The investigation therefore treats every defendant as a separate causation question with its own evidentiary record.

Preserving Exposure Evidence Early

Because mesothelioma carries a grim prognosis and because the exposure evidence depends on aging witnesses and decades-old records, preserving proof quickly is critical. Where a diagnosed plaintiff is able to testify, counsel may seek an expedited or preservation deposition so the plaintiff's own account of the products and tasks is captured while possible. California also provides for trial preference in cases involving a party with a limited life expectancy (Code of Civil Procedure §36), which can move a mesothelioma case to trial on an accelerated schedule. Co-worker witnesses, who often supply the product-identification testimony that the plaintiff cannot, should be located and interviewed promptly. The combination of preserved testimony, historical product records, and expert medical analysis is what allows a plaintiff to meet the two-part McGonnell/Rutherford standard even though the exposures occurred many years before the diagnosis. Delay is the enemy of proof in these cases: once a key co-worker dies or a supplier’s records are destroyed, the product identification that ties a defendant to the plaintiff’s exposure may be lost for good. That is why experienced asbestos counsel begin building the exposure record immediately after diagnosis, rather than waiting for the litigation to develop, and why a prompt consultation can preserve evidence that would otherwise disappear. For families confronting a diagnosis, acting quickly is not merely a legal formality but a practical necessity, because the window to capture the testimony and documents that prove exposure narrows with every passing month.

Related Guides

For related reading, see our guide on asbestos strict-liability failure-to-warn and the state-of-the-art defense and our mesothelioma and asbestos practice overview. Proving exposure to each defendant’s product is the heart of a California asbestos case.

Speak With a California Mesothelioma Attorney

If you or a loved one has been diagnosed with mesothelioma or another asbestos-related disease, the ability to prove exposure to each defendant’s product will shape the case. Trembach Law Firm develops the work history, product identification, and expert medical evidence required under McGonnell, Lineaweaver, and Rutherford to meet California’s two-part causation standard. Call (213) 645-2246 for a confidential consultation. Anatolii Trembach holds an LL.M. and is admitted to the California Bar. Because witnesses and records grow scarcer over time, it is important to act promptly.

This article provides general information about California asbestos law and is not legal advice. Asbestos causation is fact-specific and depends on medical and exposure evidence. Consult a qualified mesothelioma attorney about your particular situation.

Contact Trembach Law Firm at (818) 514-7680 for a confidential consultation.

Trembach Law Firm | 27001 Agoura Road, Suite 350, Calabasas, CA 91301